Shares of Schrödinger, Inc. (NASDAQ:SDGR – Get Free Report) have been assigned an average rating of “Moderate Buy” from the nine research firms that are currently covering the firm, MarketBeat reports. Three analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is $43.50.
Several research analysts have recently commented on the company. Bank of America lowered their price target on Schrödinger from $38.00 to $32.00 and set a “neutral” rating for the company in a research report on Thursday, February 29th. KeyCorp lowered their price target on Schrödinger from $38.00 to $33.00 and set an “overweight” rating for the company in a research report on Thursday, February 29th. Craig Hallum reduced their price objective on Schrödinger from $40.00 to $35.00 and set a “buy” rating on the stock in a research note on Friday, January 19th. Citigroup reduced their price objective on Schrödinger from $47.00 to $39.00 and set a “buy” rating on the stock in a research note on Thursday, February 29th. Finally, TD Cowen initiated coverage on Schrödinger in a research note on Friday, January 26th. They issued an “outperform” rating and a $42.00 price target on the stock.
Read Our Latest Research Report on Schrödinger
Insider Transactions at Schrödinger
Institutional Trading of Schrödinger
A number of hedge funds and other institutional investors have recently made changes to their positions in the company. TrueMark Investments LLC increased its position in shares of Schrödinger by 13.5% during the first quarter. TrueMark Investments LLC now owns 46,572 shares of the company’s stock worth $1,257,000 after purchasing an additional 5,551 shares in the last quarter. PNC Financial Services Group Inc. grew its holdings in shares of Schrödinger by 186.7% during the fourth quarter. PNC Financial Services Group Inc. now owns 2,127 shares of the company’s stock worth $76,000 after buying an additional 1,385 shares during the last quarter. Vanguard Group Inc. grew its holdings in shares of Schrödinger by 1.2% during the fourth quarter. Vanguard Group Inc. now owns 6,776,631 shares of the company’s stock worth $242,603,000 after buying an additional 77,830 shares during the last quarter. Greenwood Capital Associates LLC grew its holdings in shares of Schrödinger by 26.4% during the fourth quarter. Greenwood Capital Associates LLC now owns 24,492 shares of the company’s stock worth $877,000 after buying an additional 5,118 shares during the last quarter. Finally, Goldman Sachs Group Inc. grew its holdings in shares of Schrödinger by 48.5% during the fourth quarter. Goldman Sachs Group Inc. now owns 410,920 shares of the company’s stock worth $14,711,000 after buying an additional 134,252 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.
Schrödinger Stock Performance
Shares of Schrödinger stock opened at $25.04 on Thursday. The firm has a market capitalization of $1.81 billion, a price-to-earnings ratio of 39.75 and a beta of 1.57. Schrödinger has a fifty-two week low of $20.76 and a fifty-two week high of $59.24. The stock has a 50 day moving average of $27.39 and a 200 day moving average of $28.42.
Schrödinger (NASDAQ:SDGR – Get Free Report) last issued its quarterly earnings data on Wednesday, February 28th. The company reported ($0.32) earnings per share for the quarter, topping the consensus estimate of ($0.44) by $0.12. The company had revenue of $74.10 million during the quarter, compared to analyst estimates of $79.12 million. Schrödinger had a negative return on equity of 23.58% and a net margin of 18.79%. The firm’s revenue for the quarter was up 30.5% compared to the same quarter last year. During the same period in the prior year, the business posted ($0.39) earnings per share. Analysts forecast that Schrödinger will post -2.73 EPS for the current year.
Schrödinger Company Profile
Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.
Featured Stories
- Five stocks we like better than Schrödinger
- Best Stocks Under $5.00
- United Airlines Soars on Earnings Beat
- What Is WallStreetBets and What Stocks Are They Targeting?
- J.B. Hunt Hits the Skids: Lower Prices to Come
- Options Trading – Understanding Strike Price
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Receive News & Ratings for Schrödinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Schrödinger and related companies with MarketBeat.com's FREE daily email newsletter.